| Page | Article - [Author(s)] | PDF | Abs. | CME | Audio | Media |
|---|
| Editorial |
|---|
CER5384  2012,30,2 Pg. 0147-0151
 | Endpoints for randomised controlled trials in systemic lupus erythematosus M. Aringer, V. Strand |  |  | | | |
| Imaging |
|---|
CER5587  2012,30,2 Pg. 0152-0155
 | Ultrasound imaging for the rheumatologist XXXVIII.
Sonographic assessment of the hip in psoriatic arthritis patients
L. Riente, A. Delle Sedie, G. Sakellariou, E. Filippucci, G. Meenagh, A. Iagnocco, E. Cioffi, G. Valesini, W. Grassi, C. Montecucco, S. Bombardieri |  |  | | | |
| Full Paper |
|---|
CER4778  2012,30,2 Pg. 0156-0163
 | A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate E. Hobl, B. Jilma, L. Erlacher, B. Duhm, M. Mustak, H. Bröll, P. Högger, B. Rizovski, R. Mader |  |  | | | |
|
CER4660  2012,30,2 Pg. 0164-0170
 | Treatment outcomes of a Numeric Rating Scale (NRS)-guided pharmacological pain management strategy in symptomatic knee and hip osteoarthritis in daily clinical practice G. Snijders, C. van den Ende, B. van den Bemt, P. van Riel, F. van den Hoogen, A. den Broeder |  |  | | | |
|
CER4418  2012,30,2 Pg. 0171-0177
 | Overexpression of decoy receptor 3 in synovial tissues of inflammatory arthritis M. Chen, W. Chen, C. Tsai, H. Liao, C. Chen, C. Chou |  |  | | | |
|
CER4738  2012,30,2 Pg. 0178-0183
 | Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis. V. Milic, B. Jekic, L. Lukovic, V. Bunjevacki, J. Milasin, I. Novakovic, T. Damnjanovic, B. Popovic, N. Maksimovic, N. Damjanov, G. Radunovic, N. Pejnovic, M. Krajinovic |  |  | | | |
|
CER4737  2012,30,2 Pg. 0184-0190
 | Attending and non-attending patients in a real-life setting of an early arthritis clinic: why do people leave clinics and where do they go? V. Nell-Duxneuner, L. Rezende, T. Stamm, M. Duer, J. Smolen, K. Machold |  |  | | | |
|
CER4754  2012,30,2 Pg. 0191-0196
 | Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients J. Payet, L. Gossec, S. Paternotte, V. Burki, A. Durnez, M. Elhai, I. Fabréguet, E. Koumakis, M. Meyer, F. Roure, M. Dougados |  |  | | | |
|
CER4624  2012,30,2 Pg. 0197-0201
 | A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease H. Hsu, S. Khare, F. Lee, K. Miner, Y. Hu, M. Stolina, N. Hawkins, Q. Chen, S. Ho, H. Min, F. Xiong, T. Boone, D. Zack |  |  | | | |
|
CER4686  2012,30,2 Pg. 0202-0207
 | The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey S. Malhan, S. Pay, S. Ataman, E. Dalkilic, A. Dinc, E. Erken, I. Ertenli, E. Ertugrul, F. Gogus, V. Hamuryudan, M. Inanc, Y. Karaarslan, O. Karadag, Y. Karakoc, G. Keskin, B. Kisacik, S. Kiraz, F. Oksel, E. Oksuz, T. Pirildar, I. Sari, M. Soy, T. Senturk, A. Taylan |  |  | | | |
|
CER4780  2012,30,2 Pg. 0208-0212
 | Rituximab in central nervous system manifestations of patients with primary Sjögren`s syndrome: results from the AIR registry. A. Mekinian, P. Ravaud, C. Larroche, E. Hachulla, B. Gombert, C. Blanchard-Delaunay, A. Cantagrel, O. Fain, J. Sibilia, J. Gottenberg, X. Mariette |  |  | | | |
|
CER4883  2012,30,2 Pg. 0213-0221
 | Proteins related to the functions of fibroblast-like synoviocytes identified by proteomic analysis H. Zhang, L. Fan, M. Zong, L. Sun, L. Lu |  |  | | | |
|
CER4673  2012,30,2 Pg. 0222-0227
 | Economic burden of osteoporosis in women: data from the 2008 French hospital database (PMSI) M. Maravic, B. Jouaneton, A. Vainchtock, V. Tochon |  |  | | | |
|
CER4740  2012,30,2 Pg. 0228-0232
 | Current limitations in the management of cardiovascular risk in rheumatoid arthritis. I. Scott, F. Ibrahim, D. Johnson, D. Scott, G. Kingsley |  |  | | | |
|
CER4540  2012,30,2 Pg. 0233-0239
 | Efficacy of a comprehensive rehabilitation programme combined with pharmacological treatment in reducing pain in a group of OA patients on a waiting list for total joint replacement R. Casale, C. Damiani, V. Rosati, F. Atzeni, P. Sarzi-Puttini, A. Nica |  |  | | | |
|
CER4881  2012,30,2 Pg. 0240-0245
 | Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy T. Hügle, H. Kovacs, I. Heijnen, T. Daikeler, U. Baisch, J. Hicks, V. Valderrabano |  |  | | | |
|
CER4444  2012,30,2 Pg. 0246-0253
 | Healthcare costs and productivity losses directly attributable to ankylosing spondylitis R. Rafia, R. Ara, J. Packham, K. Haywood, E. Healey |  |  | | | |
|
CER4476  2012,30,2 Pg. 0254-0261
 | Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis M. Seymour, F. Pétavy, F. Chiesa, H. Perry, P. Lukey, M. Binks, P. Donatien, A. Freidin, R. Eckersley, C. McClinton, K. Heath, S. Prodanovic, G. Radunovic, N. Pilipovic, N. Damjanov, P. Taylor |  |  | | | |
| Brief Paper |
|---|
CER4482  2012,30,2 Pg. 0262-0265
 | Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis Y. Lee, H. Lee, S. Choi, J. Ji, G. Song |  |  | | | |
|
CER4858  2012,30,2 Pg. 0266-0268
 | Onset of action of etanercept in rheumatoid arthritis based on patient-reported outcomes M. Dougados, M. Ripert, P. Hilliquin, O. Brocq, Y. Brault, I. Logeart |  |  | | | |
|
CER5010  2012,30,2 Pg. 0269-0271
 | Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers L. Cantarini, A. Vitale, B. Bartolomei, M. Galeazzi, D. Rigante |  |  | | | |
| Case Report |
|---|
CER4698  2012,30,2 Pg. 0272-0276
 | Acanthamoeba meningoencephalitis presenting as neuropsychiatric lupus in a pediatric patient R. Castillo, J. Garza, M. Shamszadeh, A. Reiff, K. Marzan |  |  | | | |
| Review |
|---|
CER4697  2012,30,2 Pg. 0277-0281
 | Hyaluronic acid in ankle osteoarthritis: why evidence of efficacy is still lacking? M. Abate, C. Schiavone, V. Salini |  |  | | | |
|
CER4809  2012,30,2 Pg. 0282-0289
 | Efficacy and safety of DMARDs in psoriatic arthritis: a systematic review C. Pereda, M. Nishishinya, J. Martinez Lopez, L. Carmona |  |  | | | |
| Pediatric Rheumatology |
|---|
CER4558  2012,30,2 Pg. 0290-0296
 | Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritis I. Olivieri, M. Cutro, S. D`Angelo, P. Leccese, G. Mennillo, E. Scarano, R. Abate, C. Palazzi, A. Padula |  |  | | | |
|
CER4595  2012,30,2 Pg. 0297-0301
 | HMOX1 promoter (GT)n polymorphim is associated with childhood-onset systemic lupus erythematosus but not with juvenile rheumatoid arthritis in a Mexican population E. Cordova, A. Martínez-Hernández, J. Ramírez-Bello, R. Velázquez-Cruz, F. Centeno, V. Baca, L. Orozco |  |  | | | |
|
CER4721  2012,30,2 Pg. 0302-0307
 | Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study C. Leiskau, A. Thon, M. Gappa, F. Dressler |  |  | | | |
| Letter to the Editor |
|---|
CER4743  2012,30,2 Pg. 0308
 | Development of the Rheumatic Disease Illness Perception Questionnaire (RD-IPQ) reliability, validity and responsiveness
I. Lřchting, A. Garratt, M. Klokkerud, E. Fjerstad |  |  | | | |
|
CER4970  2012,30,2 Pg. 0309-0310
 | Mechanobiology likely contributes to immunobiology pathways in the pathogenesis of ankylosing spondyltitis B. Andonian, K. Prus, A. Masi |  |  | | | |
|
CER4785  2012,30,2 Pg. 0311-0312
 | H1N1 influenza outcome in rheumatic patients under biological therapy V. Bournia, C. Sfontouris, M. Konsta, A. Iliopoulos |  |  | | | |
|